Cargando…

Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma

The main prognostic factors for patients with head and neck cancer are the tumour site and stage, yet immunological and metabolic factors are certainly important, although knowledge is still limited. Expression of the biomarker p16INK4a (p16) in oropharyngeal cancer tumour tissue is one of the few b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sandström, Karl, Ehrsson, Ylva Tiblom, Sellberg, Felix, Johansson, Hemming, Laurell, Göran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961007/ https://www.ncbi.nlm.nih.gov/pubmed/36835246 http://dx.doi.org/10.3390/ijms24043838

Ejemplares similares

Serum Proteomics in Patients with Head and Neck Cancer: Peripheral Blood Immune Response to Treatment
por: Astradsson, Thorsteinn, et al.
Publicado: (2022)

Systemic Inflammatory Reaction in Patients With Head and Neck Cancer—An Explorative Study
por: Astradsson, Thorsteinn, et al.
Publicado: (2019)

Nutritional surveillance and weight loss in head and neck cancer patients
por: Ehrsson, Ylva Tiblom, et al.
Publicado: (2011)

Higher Risk of Recurrence in Patients Treated for Head and Neck Cancer with Low BMI and Elevated Levels of C-Reactive Protein
por: Spiegelberg, Diana, et al.
Publicado: (2022)

Predicting Return to Work after Head and Neck Cancer Treatment Is Challenging Due to Factors That Affect Work Ability
por: Tiblom Ehrsson, Ylva, et al.
Publicado: (2023)

Addressing symptoms that affect patients’ eating according to the Head and Neck Patient Symptom Checklist(©)
por: Granström, Brith, et al.
Publicado: (2022)

Head and neck cancer patients’ perceptions of quality of life and how it is affected by the disease and enteral tube feeding during treatment
por: Ehrsson, Ylva Tiblom, et al.
Publicado: (2015)

Longitudinal Changes in the Fatty Acid Profile in Patients with Head and Neck Cancer: Associations with Treatment and Inflammatory Response
por: Christou, Constantina N, et al.
Publicado: (2022)

Internet-based support for informal caregivers to individuals with head and neck cancer (Carer eSupport): a study protocol for the development and feasibility testing of a complex online intervention
por: Langegård, Ulrica, et al.
Publicado: (2022)

Mapping Health-Related Quality of Life, Anxiety, and Depression in Patients with Head and Neck Cancer Diagnosed with Malnutrition Defined by GLIM
por: Ehrsson, Ylva Tiblom, et al.
Publicado: (2021)

Positive Design Framework for Carer eSupport: Qualitative Study to Support Informal Caregivers of Patients With Head and Neck Cancer in Sweden
por: Ahmad, Awais, et al.
Publicado: (2023)

Mapping of human papilloma virus, p16, and epstein‐barr virus in non‐malignant tonsillar disease
por: Holm, Anna, et al.
Publicado: (2019)

Early self-care rehabilitation of head and neck cancer patients
por: Ahlberg, Alexander, et al.
Publicado: (2011)

Integrated analysis of lncRNA-associated ceRNA network in p16-positive and p16-negative head and neck squamous cell carcinoma
por: Yang, Yifan, et al.
Publicado: (2022)

p16 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma: Association With Prognostic Parameters
por: Hashmi, Atif A, et al.
Publicado: (2020)

Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16
por: Biesaga, Beata, et al.
Publicado: (2017)

Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas
por: Chang, Pei-Hung, et al.
Publicado: (2021)

Assessment of immunohistochemical expression of p16 in head and neck squamous cell carcinoma and their correlation with clinicopathological parameters
por: Pandey, Pinki, et al.
Publicado: (2021)

High prevalence of p16 genetic alterations in head and neck tumours
por: Miracca, E C, et al.
Publicado: (1999)

The role of p16 as a biomarker in nonoropharyngeal head and neck cancer
por: Vitzthum, Lucas K., et al.
Publicado: (2018)

Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients
por: Jiarpinitnun, Chuleeporn, et al.
Publicado: (2020)

Significance of the Neutrophil-to-Lymphocyte Ratio in p16-Negative Squamous Cell Carcinoma of Unknown Primary in Head and Neck
por: Xu, Chunmiao, et al.
Publicado: (2020)

Human papillomavirus DNA and p16 expression in head and neck squamous cell carcinoma in young French patients
por: Molimard, Chloé, et al.
Publicado: (2021)

Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer
por: Smith, Elaine M, et al.
Publicado: (2010)

Telomerase activation cooperates with inactivation of p16 in early head and neck tumorigenesis
por: Soria, J C, et al.
Publicado: (2001)

Low p16 Cytoplasmic Staining Predicts Poor Treatment Outcome in Patients with p16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving TPF Induction Chemotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2023)

An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma
por: Carper, Miranda B., et al.
Publicado: (2019)

No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours
por: Jefferies, S, et al.
Publicado: (2001)

Predictive Values of MRI and PET Derived Quantitative Parameters for Patterns of Failure in Both p16+ and p16– High Risk Head and Neck Cancer
por: Cao, Yue, et al.
Publicado: (2019)

Exploring the roles of HPV16 variants in head and neck squamous cell carcinoma: current challenges and opportunities
por: Cochicho, Daniela, et al.
Publicado: (2021)

Impact of p16 status on pro- and anti-angiogenesis factors in head and neck cancers
por: Baruah, P, et al.
Publicado: (2015)

Dual role for p16 in the metastasis process of HPV positive head and neck cancers
por: Dok, Rüveyda, et al.
Publicado: (2017)

Expression of p16, p53, and TLR9 in HPV-Associated Head and Neck Squamous Cell Carcinoma: Clinicopathological Correlations and Potential Prognostic Significance
por: Wang, Shu, et al.
Publicado: (2021)

Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma
por: Navran, Arash, et al.
Publicado: (2023)

Treatment failure patterns are similar between p16− and p16+ oropharyngeal squamous cell carcinomas
por: Hamill, Chelsea S., et al.
Publicado: (2022)

Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes
por: Arsa, Lalida, et al.
Publicado: (2021)

Epidemiological Study of p16 Incidence in Head and Neck Squamous Cell Carcinoma 2005–2015 in a Representative Northern European Population
por: Mylly, Mari, et al.
Publicado: (2022)

Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma
por: Xie, Xiujie, et al.
Publicado: (2013)

A HPV16-related prognostic indicator for head and neck squamous cell carcinoma
por: Zhang, Qian, et al.
Publicado: (2020)

Sexual and contraceptive behavior among female university students in Sweden – repeated surveys over a 25-year period
por: Stenhammar, Christina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_19ui031t6i2ubddcn607klqbpc